Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect
Other
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This paper investigates the role of sphingosine 1-phosphate signaling in uterine fibroids and its potential involvement in the pro-fibrotic effects of activin A.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To explore the link between sphingosine 1-phosphate (S1P) signaling and leiomyoma and the possible S1P cross-talk with the fibrotic effect of activin A.
DESIGN: Case-control laboratory study.
SETTING: University institute and university hospital.
PATIENT(S): Patients with uterine fibroids (n = 26).
INTERVENTIONS(S): Tissue specimens of leiomyoma and normal myometrium were obtained from patients undergoing myomectomy or total hysterectomy.
MAIN OUTCOME MEASURE(S): Expression of mRNA levels of the enzyme involved in S1P metabolism, S1P receptors, and S1P transporter Spns2 was evaluated in matched leiomyoma/myometrium specimens and cell populations. The effects of inhibition of S1P metabolism and signaling was evaluated on activin A-induced fibrotic action in leiomyoma cell lines.
RESULT(S): The expression of the enzymes responsible for S1P formation, sphingosine kinase (SK) 1 and 2, and S1P2, S1P3, and S1P5 receptors was significantly augmented in leiomyomas compared with adjacent myometrium. In leiomyoma cells, but not in myometrial cells, activin A increased mRNA expression levels of SK1, SK2, and S1P2. The profibrotic action of activin A was abolished when SK1/2 were inhibited or S1P2/3 were blocked. Finally, S1P augmented by itself mRNA levels of fibrotic markers (fibronectin, collagen 1A1) and activin A in leiomyomas but not in myometrial cells.
CONCLUSION(S): This study shows that S1P signaling is dysregulated in uterine fibroids and involved in activin A-induced fibrosis, opening new perspectives for uterine fibroid treatment.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor β-induced fibrosis 2020
- [Histological and biochemical studies of collagen in human uterine leiomyomas] 1985
Cited by (2)
References (59)
- [Histological and biochemical studies of collagen in human uterine leiomyomas] via openalex
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure via openalex
- Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor β-induced fibrosis via openalex
- doi:10.1016/j.tcb.2011.09.003 via openalex
- doi:10.1038/nprot.2008.73 via openalex
- doi:10.1006/meth.2001.1262 via openalex
- doi:10.1177/1933719114542019 via openalex
- doi:10.1194/jlr.m800496-jlr200 via openalex
- doi:10.1016/j.biochi.2019.01.018 via openalex
- doi:10.21037/tcr.2017.10.05 via openalex
- doi:10.1016/j.ajpath.2017.06.017 via openalex
- doi:10.1016/j.bbamcr.2018.12.007 via openalex
- doi:10.1055/s-0030-1251475 via openalex
- doi:10.1038/nrd3248 via openalex
- doi:10.1126/science.1112063 via openalex
- doi:10.1093/humupd/dmx032 via openalex
- doi:10.1111/j.1365-2265.2008.03207.x via openalex
- doi:10.1371/journal.pone.0182329 via openalex
- doi:10.3390/ijms19051498 via openalex
- doi:10.1016/j.cellsig.2008.10.007 via openalex
- doi:10.1016/j.fertnstert.2016.01.032 via openalex
- doi:10.1016/j.bpobgyn.2015.11.015 via openalex
- doi:10.1007/978-3-030-21162-2_7 via openalex
- doi:10.1136/thoraxjnl-2011-200026 via openalex
- doi:10.1385/1-59259-372-0:69 via openalex
- doi:10.1126/science.aar5551 via openalex
- doi:10.1074/jbc.m109.068395 via openalex
- doi:10.1016/j.cellsig.2018.02.001 via openalex
- doi:10.3389/fimmu.2017.01242 via openalex
- doi:10.1038/srep32119 via openalex
- doi:10.3390/ijms21062064 via openalex
- doi:10.1016/j.ijrobp.2006.08.058 via openalex
- doi:10.3389/fphys.2013.00338 via openalex
- W6717593941 via openalex
- doi:10.1016/j.ab.2012.10.010 via openalex
- doi:10.1016/j.bbalip.2012.06.013 via openalex
- doi:10.1002/1878-0261.12048 via openalex
- doi:10.1038/s41598-019-47048-0 via openalex
- doi:10.3389/fphar.2018.01504 via openalex
- doi:10.1055/s-0037-1607265 via openalex
- doi:10.1016/j.cellsig.2011.07.010 via openalex
- doi:10.1186/1748-717x-4-66 via openalex
- doi:10.1016/j.jhep.2013.02.021 via openalex
- doi:10.1016/j.fertnstert.2013.03.007 via openalex
- doi:10.1177/1933719115592710 via openalex
- doi:10.1210/jc.2013-2623 via openalex
- doi:10.1007/s00441-015-2324-3 via openalex
- doi:10.1016/j.fertnstert.2004.04.030 via openalex
- doi:10.1055/s-0030-1251476 via openalex
- doi:10.1210/jc.2010-0501 via openalex
- doi:10.1681/asn.2016030306 via openalex
- doi:10.1096/fj.13-228528 via openalex
- doi:10.1016/j.fertnstert.2014.05.013 via openalex
- doi:10.1210/en.2006-0291 via openalex
- doi:10.3390/ijms19010139 via openalex
- doi:10.1091/mbc.e09-09-0812 via openalex
- doi:10.1084/jem.20110551 via openalex
- doi:10.3109/14767058.2014.921675 via openalex
- doi:10.1016/j.bpobgyn.2015.08.018 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-14T06:20:05.154166+00:00
- pubmed
- last seen: 2026-10-08T21:29:46.384990+00:00
- unpaywall
- last seen: 2026-10-09T06:36:44.367587+00:00
License: CC0
· commercial use OK